As of 2025-07-14, the Fair Value of Travere Therapeutics Inc (TVTX) is -12.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 16.47 USD, the upside of Travere Therapeutics Inc is -177.51%.
With the market price of 16.47 USD and our fair value calculation, Travere Therapeutics Inc (TVTX) is not a good investment. Investing in TVTX stocks now will result in a potential loss of 177.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -169.40 | -180.10 | -278.50 | -111.40 | -321.55 | -212.19 |
| YoY growth | -15.71% | -6.32% | -54.64% | 60.00% | -188.64% | -41.06% |
| Market Cap (mil) | 1,462.54 |
| P/E | |
| Forward P/E |
| EPS | -2.55 |
| Avg earnings growth rate | -41.06% |
| TTM earnings | -226.71 |